12.07.2015 Views

Foundation of and Advances in IVIVC - PQRI

Foundation of and Advances in IVIVC - PQRI

Foundation of and Advances in IVIVC - PQRI

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Genesis <strong>of</strong> the Workshop• Orig<strong>in</strong> <strong>of</strong> <strong>IVIVC</strong> – 1980s– <strong>IVIVC</strong> Workshops(1) 1985, Report- Pharm Res 4, 75-77, 1987;(2) 1988, Report – Pharm Res 7,975-982, 1990• FDA Guidance <strong>in</strong> 1997


Application <strong>of</strong> <strong>IVIVC</strong> <strong>in</strong>Formulation Development• Effective utilization <strong>of</strong> <strong>IVIVC</strong> concept. Workshop <strong>of</strong>ferspossible ways to overcome problems through effectiveutilization <strong>of</strong> <strong>IVIVC</strong> data.• <strong>IVIVC</strong> is an important tool <strong>in</strong> development <strong>and</strong> evaluation <strong>of</strong>pharmaceutical dosage forms, especially Modified Releasedosage forms• Contribute <strong>in</strong> development <strong>of</strong> quality <strong>of</strong> pharmaceuticalproducts• FDA Guidance (1997) – Scientists <strong>in</strong>dicate that it is not easyto establish <strong>IVIVC</strong> based on exist<strong>in</strong>g guidance• An <strong>in</strong>teractive workshop – exchange between speakers <strong>and</strong>participants


Potential Constra<strong>in</strong>ts <strong>in</strong>Establish<strong>in</strong>g <strong>IVIVC</strong>• Concerns –• Difficult to develop <strong>and</strong> implement <strong>IVIVC</strong>• Practical use <strong>of</strong> <strong>IVIVC</strong>• Can the exist<strong>in</strong>g tools be used to establishproduct specifications?


For Discussion• An empirical approach to a MR Formulationdevelopment is to retard the rate <strong>of</strong> release <strong>of</strong> theactive <strong>in</strong>gredient, ideally, <strong>in</strong> a controlled <strong>and</strong>predictable fashion from a concept formulation.• A m<strong>in</strong>imum 3 formulations with different rate <strong>of</strong>release.• Early BA studies to ascerta<strong>in</strong> the potential <strong>IVIVC</strong>correlation.• Adjust<strong>in</strong>g rate <strong>of</strong> release from <strong>and</strong> f<strong>in</strong>e-tun<strong>in</strong>g thedesired formulation.• Repeat BA <strong>and</strong> or BE study to confirm result.


Bioavailability <strong>and</strong> Bioequivalence• BA <strong>and</strong> BE parameters are mean<strong>in</strong>gful if theycan be used to determ<strong>in</strong>e productspecifications <strong>and</strong> production criteria.• In-vitro analytical specifications <strong>and</strong> productpr<strong>of</strong>ile (attributes) will have to reflect <strong>in</strong>-vivocharacteristics <strong>of</strong> the product.• Statistical approaches will assist <strong>in</strong> a safe way<strong>of</strong> translat<strong>in</strong>g <strong>in</strong>-vivo data to <strong>in</strong>-vitrospecifications


Application <strong>of</strong> <strong>IVIVC</strong> <strong>in</strong> FormulationObjectivesDevelopment• Review the current status <strong>of</strong> <strong>IVIVC</strong>• Discuss applications <strong>and</strong> potential benefits <strong>of</strong> <strong>IVIVC</strong>• Review <strong>and</strong> evaluate different methodologies <strong>and</strong> theirpotential use <strong>in</strong> <strong>IVIVC</strong> Assessment• Assess advantages <strong>and</strong> limitations for <strong>IVIVC</strong> <strong>in</strong>formulation development – when <strong>and</strong> how it may beestablished.• Develop the basis for a summary paper on <strong>IVIVC</strong> <strong>and</strong>publication as a <strong>PQRI</strong> document.


Application <strong>of</strong> <strong>IVIVC</strong> <strong>in</strong> FormulationDevelopmentProgram – Day 1• <strong>Foundation</strong> <strong>and</strong> Advantages <strong>in</strong> <strong>IVIVC</strong>• New methodologies Assessment– Simulation <strong>of</strong> <strong>IVIVC</strong>• Breakout Sessions (4, A-D)Program – Day 2• Application <strong>of</strong> <strong>IVIVC</strong>• Breakout Sessions (4, E-H)• Where do we go from here?• Conclusions <strong>and</strong> Next Steps

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!